|
|
|
|
5-HT receptor
|
| |
|
| |
In the field of neurochemistry, 5-HT receptors are receptors for the neurotransmitter and peripheral signal mediator serotonin, also known as 5-hydroxytryptamine or 5-HT. 5-HT receptors are located on the cell membrane of nerve cells and other cell types including smooth muscle in animals, and mediate the effects of serotonin as the endogenous ligand and of a broad range of pharmaceutical and hallucinogenic drugs. 5-HT receptors affect the release and activity of other neurotransmitters such as glutamate, dopamine and GABA.

Discussion
Ask a question about '5-HT receptor'
Start a new discussion about '5-HT receptor'
Answer questions from other users
|
Encyclopedia
In the field of neurochemistry, 5-HT receptors are receptors for the neurotransmitter and peripheral signal mediator serotonin, also known as 5-hydroxytryptamine or 5-HT. 5-HT receptors are located on the cell membrane of nerve cells and other cell types including smooth muscle in animals, and mediate the effects of serotonin as the endogenous ligand and of a broad range of pharmaceutical and hallucinogenic drugs. 5-HT receptors affect the release and activity of other neurotransmitters such as glutamate, dopamine and GABA. 5-HT2A receptors increase the activity of glutamate in many areas of the brain, while some other serotonin receptors have the effect of suppressing glutamate. Increased stimulation of 5-HT2A receptors seem to oppose the therapeutic actions of increased stimulation of other serotonin receptors in anti-depressant and anxiolytic treatments.
Classification With the exception of the 5-HT3 receptor, a ligand gated ion channel, all other 5-HT receptors are G protein coupled seven transmembrane (or heptahelical) receptors that activate an intracellular second messenger cascade.
Families
| Family | Type | Mechanism
>-
| 5-HT1 | Gi/Go coupled | decreasing cellular levels of cAMP
|-
| 5-HT2 | Gq/G11 coupled | increasing cellular levels of inositol trisphosphate (IP3) and diacylglycerol (DAG)
|-
| 5-HT3 | ligand-gated Na+ and K+ cation channel | depolarizing plasma membrane
|-
| 5-HT4 | Gs coupled | -
| 5-HT5A | G protein coupled; the primary coupling appears to be through Gi/o | inhibiting adenylate cyclase activity. | | 5-HT6 | Gs coupled | -
| 5-HT7 | Gs coupled | increasing cellular levels of cAMP |
Specific proteins/genes Within these general classes of 5-HT receptors, a number of specific types have been characterized:
Summary of characterized 5-HT receptors with selected high affinity agonist and antagonist ligands, both ones of major importance and others | | Receptor | Gene | Actions | Agonists | Antagonists |
|---|
| 5-HT1A | |
- CNS: neuronal inhibition, behavioural effects (sleep, feeding, thermoregulation, aggression, anxiety)
| buspironeLSDpsilocinMDMA (speculated)5-CT8-OH-DPATflesinoxanU-92016Avilazodone | ergotaminepindololyohimbinemethiothepinrobalzotanspiperoneWAY-100135WAY-100635 |
|---|
| 5-HT1B | | CNS: presynaptic inhibition, behavioural effectsvascular: pulmonary vasoconstriction | ergotaminesumatriptan | risperidoneyohimbinemetergolinemethiothepin |
|---|
| 5-HT1D | | CNS: locomotion, anxiety;vascular: cerebral vasoconstriction | sumatriptan5-(Nonyloxy)tryptamine | ergotamineyohimbinemetergolinemethiothepin |
|---|
| 5-HT1E | | | BRL-54443LSD (very low) | |
|---|
| 5-HT1F | | | BRL-54443LY-334,370LY-344,864 |
|---|
| 5-HT2A | | CNS: neuronal excitation, behavioural effects, learning, anxietysmooth muscle: contraction, vasoconstriction / vasodilatationplatelets: aggregation | mescalinepsilocinDOIa-methyl-5-HT5-MeO-AMTDMTLSD“Bromo-DragonFLY”TCB-225I-NBOMe | ketanserinmirtazapinenefazodonepizotifentrazodoneatypical antipsychoticscyproheptadine |
|---|
| 5-HT2B | | stomach: contraction | LSDBW-723C86Fenfluraminea-methyl-5-HTDOIMDMA | yohimbineRS-127,445SB-204,741LY-272,015 |
|---|
| 5-HT2C | | CNS: anxiety, choroid plexus: cerebrospinal fluid (CSF) secretion | LorcaserinLSDpsilocina-methyl-5-HTDOIA-372,159YM-348 | fluoxetinemethysergideagomelatinemesulergineRS-102,221SB-242,084 |
|---|
| 5-HT3 | | CNS, PNS: neuronal excitation, anxiety, emesis | 2-methyl-5-HTQuipazineRS-56812 | alosetronmemantinemetoclopramide (high doses)mirtazapineondansetronrenzapride |
|---|
| 5-HT4 | | GIT: gastrointestinal motilityCNS: neuronal excitation, learning, memory | cisapridemetoclopramidetegaserod5-MTrenzaprideBIMU-8RS 67333 | GR-113,808Piboserod |
|---|
| 5-HT5A | | CNS (cortex, hippocampus, cerebellum): unknown | LSD5-CT | SB-699,551-A |
|---|
| 5-HT6 | | CNS: regulates glutamate and acetylcholine release | LSDEMDTEMD-386,088 | SB-271,046SB-258,585SB-357,134SB-399,885 |
|---|
| 5-HT7 | | CNS, GIT, blood vessels: unknown | 5-CTLSDAS-19 | risperidonemethiothepin |
|---|
Note that there is no 5-HT1C receptor since, after the receptor was cloned and further characterized, it was found to have more in common with the 5-HT2 family of receptors and was redesignated as the 5-HT2C receptor.
Therapeutic modulation
Various drugs are used to modulate the 5-HT system including some antidepressants, anxiolytics, antiemetics, antipsychotics and anti-migraine agents.
External links
|
| |
|
|